US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 99.630
  • +2.080+2.13%
Close Nov 6 16:00 ET
  • 101.320
  • +1.690+1.70%
Pre 08:14 ET
6.33BMarket Cap-47669P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Blueprint Medicines Q3 2024 Earnings Date

Currency：USDOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
127.47M
128.18M
+717.57K
Beat Est.
+125.34%
+126.61%
+0.56%
EPS
-0.97
-0.89
+0.08
Beat Est.
+55.82%
+59.55%
+8.44%
Analyst Rating
Buy

Nov 7, 2024

Blueprint Medicines Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 155.856M--
--2024/Q4-- / 145.333M--
Oct 30, 20242024/Q3128.184M / 127.466M--
Aug 1, 20242024/Q2138.157M / 103.938M--
May 2, 20242024/Q196.116M / 81.445M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 155.856M--
--2024/Q4-- / 145.333M--
Oct 30, 20242024/Q3128.184M / 127.466M--
Aug 1, 20242024/Q2138.157M / 103.938M--
May 2, 20242024/Q196.116M / 81.445M--

Unlock Free Earnings Estimates

Blueprint Medicines Earnings Reports

  • Blueprint Medicines | 10-Q: Q3 2024 Earnings Report

    Oct 30 16:32 ET

  • Blueprint Medicines | 10-Q: Q2 2024 Earnings Report

    Aug 1 16:52 ET

  • Blueprint Medicines | 10-Q: Q1 2024 Earnings Report

    May 2 16:51 ET

  • Blueprint Medicines | 10-K: FY2023 Annual Report

    Feb 15 22:20 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 7, 2024

    Buy

    • Buy

      63.64%

    • Hold

      36.36%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Cancer Research
    Cancer Research
    Intraday-1.53%